Table 1.
Baseline Patient Demographics.
| Characteristics | No. of Patients | |
|---|---|---|
| Age, years | 23 | |
| Mean | 70.2 | |
| Range | 52.3 – 85.9 | |
| ECOG PS | ||
| 0 | 6 (26.1%) | |
| 1 | 17 (73.9%) | |
| PSA | ||
| Mean (SD) | 62.2 (55.5) | |
| Range | 8.4 – 195.5 | |
| Disease Status | ||
| Rising PSA Only | 4 (17.4%) | |
| Osseous Metastasis Only | 7 (30.4%) | |
| Measurable Disease | 12 (52.2%) | |
| Gleason Score | ||
| ≤ 6 | 7 (30.4%) | |
| 7 | 8 (34.8%) | |
| 8 | 3 (13.0%) | |
| 9 | 3 (13.0%) | |
| Unknown | 2 (8.7%) | |
| Prior Therapy | ||
| Hormonal Therapy | 23 (100%) | |
| Immunotherapy | 1 (4.3%) | |
| Radiotherapy1 | 12 (52.2%) | |
| Surgery2 | 12 (52.2%) | |
| Other | 1 (4.3%) | |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; PSA, Prostate specific antigen; SD, Standard Deviation.
1
Includes primary and palliative radiation.
2
Includes two patients who had orchiectomy